Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Cidara Therapeutics Inc’s stock clocked out at $71.22, up 9.82% from its previous closing price of $64.85. In other words, the price has increased by $9.82 from its previous closing price. On the day, 0.98 million shares were traded. CDTX stock price reached its highest trading level at $71.49 during the session, while it also had its lowest trading level at $65.8.
Ratios:
To gain a deeper understanding of CDTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.45 and its Current Ratio is at 16.45. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 11 ’25 when Davarpanah Nicole Negar sold 474 shares for $62.86 per share. The transaction valued at 29,797 led to the insider holds 31,418 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares of CDTX for $99,999,988 on Jun 26 ’25. The Director now owns 3,365,523 shares after completing the transaction at $44.00 per share. On Jun 02 ’25, another insider, Mineo Chrysa, who serves as the Director of the company, bought 2,270 shares for $21.71 each. As a result, the insider paid 49,281 and bolstered with 2,270 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDTX now has a Market Capitalization of 1806000512 and an Enterprise Value of 1297758336.
Stock Price History:
The Beta on a monthly basis for CDTX is 1.26, which has changed by 5.3194323 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, CDTX has reached a high of $69.36, while it has fallen to a 52-week low of $10.14. The 50-Day Moving Average of. The Stock is 14.28%, while the 200-Day Moving Average is calculated to be 111.85%.
Shares Statistics:
It appears that CDTX traded 839.01K shares on average per day over the past three months and 710520 shares per day over the past ten days. A total of 23.23M shares are outstanding, with a floating share count of 19.37M. Insiders hold about 23.61% of the company’s shares, while institutions hold 84.29% stake in the company. Shares short for CDTX as of 1756425600 were 2150846 with a Short Ratio of 2.56, compared to 1753920000 on 2186856. Therefore, it implies a Short% of Shares Outstanding of 2150846 and a Short% of Float of 8.49.
Earnings Estimates
. The Stock of Cidara Therapeutics Inc (CDTX) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$1.5, with high estimates of -$0.82 and low estimates of -$2.03.
Analysts are recommending an EPS of between -$4.0 and -$6.99 for the fiscal current year, implying an average EPS of -$6.01. EPS for the following year is -$7.84, with 6.0 analysts recommending between -$3.9 and -$13.51.
